Side effects of AZT prophylaxis after occupational exposure to HIV-infected blood
- 1 September 1994
- journal article
- research article
- Published by Springer Science and Business Media LLC in Annals of Hematology
- Vol. 69 (3), 135-138
- https://doi.org/10.1007/bf01695694
Abstract
It was the objective of this study to document and evaluate AZT-induced short-term toxicity in healthy individuals. The study was designed as a longitudinal monocentric side-effect monitoring study with prospective data collection. It was carried out at the Cologne University Hospital. The study population comprised health care workers who were taking AZT prophylaxis after accidental exposure to HIV-infected blood. Fourteen individuals were included into the study; seven of them discontinued treatment prematurely, five due to severe subjective symptoms. In case of one worker AZT had to be stopped due to severe neutropenia (800 cells /μl) with signs of upper respiratory tract infection. Four of 11 individuals taking AZT for at least 4 weeks developed neutropenia (2 WHO I, 1 WHO II, 1 WHO III). All other laboratory parameters stayed within normal range. In particular, no anemia was observed. In conclusion: Compared with other studies more neutropenias are observed. Due to side effects 50% of the workers discontinued AZT administration prematurely. The data presented herein show that AZT causes considerable side effects which must be weighed against the potential protective antiviral effect.Keywords
This publication has 8 references indexed in Scilit:
- Surveillance of HIV Infection and Zidovudine Use among Health Care Workers after Occupational Exposure to HIV-Infected BloodAnnals of Internal Medicine, 1993
- Pre- and postexposure chemoprophylaxis: evidence that 3'-azido-3'-dideoxythymidine inhibits feline leukemia virus disease by a drug-induced vaccine responseAntimicrobial Agents and Chemotherapy, 1992
- Zidovudine prophylaxis after accidental exposure to HIVAIDS, 1992
- Postexposure Prophylaxis with Zidovudine Suppresses Human Immunodeficiency Virus Type 1 Infection in SCID-hu Mice in a Time-Dependent MannerThe Journal of Infectious Diseases, 1991
- Pathophysiology and management of HIV-associated hematologic disordersBlood, 1989
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Suppression of mouse viraemia and retroviral disease by 3′-azido-3′-deoxythymidineNature, 1986